Skip to content

Clinical trials

Phase 4 Shock, Cardiogenic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Shock, Cardiogenic Phase: Phase 4 Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20091
20111
20131
20151
20171
20184
20191
20201
20223
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting6
Not yet recruiting2
Terminated2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ottawa Heart Institute Research Corporation3
Samsung Medical Center2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Beijing Anzhen Hospital1
Central Hospital, Nancy, France1
Charles University, Czech Republic1
Deutsches Herzzentrum Muenchen1
Faculty Hospital Kralovske Vinohrady1
First Affiliated Hospital of Wannan Medical College1
Hospital Universitario Ramon y Cajal1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Shock, Cardiogenic23
Myocardial Infarction6
Heart Failure3
Acute Coronary Syndrome1
Acute Kidney Injury1
Acute Lung Injury1
Cardiac Output, Low1
Edema1
Infarction1
Ketosis1

Trials

Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.